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Abstract    
Summary Bone mass achievement predicts later fracture risk. This population-based study describes bone 
mineral density levels (BMD) and associated factors in Norwegian adolescents. Compared with 
international reference ranges, BMD levels appear higher and physical activity levels are positively 
associated with BMD.  
Purpose Norway has one of the highest reported incidences of osteoporotic fractures. Maximization of peak 
bone mass may prevent later fractures. This population-based study compared BMD levels of Norwegian 
adolescents with international reference ranges and explored associated factors.   
Methods All first year upper secondary school students, aged 15-19 years in the Tromsø region were 
invited to the Fit Futures study in 2010-2011. Over 90% of the invited participants attended, 508 girls and 
530 boys. BMD was measured at total hip, femoral neck and total body by dual x-ray absorptiometry. 
Lifestyle variables were collected by self-administered questionnaires and interviews. All analyses were 
performed sex stratified, using linear regression models.   
Results In girls mean BMD (SD) was 1.060 (0.124), 1.066 (0.123) and 1.142 (0.077) g/cm² at the total hip, 
femoral neck and total body respectively. In boys corresponding values were 1.116 (0.147), 1.103 (0.150) 
and 1.182 (0.097), with significant higher values than the Lunar pediatric reference at 16 years of age In 
girls, height and self-reported intensive physical activity of more than four hours a week and early sexual 
maturation were positively associated with BMD at both femoral sites (p<0.047). Among boys age, height, 
body mass index, physical activity and alcohol intake were positively (p<0.038), whereas early stages of 
sexual maturation and smoking was negatively (p<0.047) related to BMD.  
Conclusions Despite the heavy fracture burden, Norwegian adolescents´ BMD levels are higher than age-
matched Caucasians. Physical activity is associated with 1 SD increased BMD levels in those involved in 
competition or hard training.  
 
Keywords Population-based study – Adolescents – DXA – Sexual maturation – Physical activity – Bone 
mineral density   
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Introduction 
 
Osteoporotic fractures constitute a major economic burden for the health care sector and communities in 
western societies [1-3]. Hip fractures are regarded as the most serious osteoporotic fracture and Norway has 
one of the highest reported incidences of hip fractures in the world [4]. Bone mineral density (BMD) is a 
strong predictor of fracture risk [5]. Research on fracture risk has primarily focused on bone mass in the 
elderly. However, there is a growing awareness of the importance of bone mass during growth, as a 
compensation for the later inevitable bone loss and prevention of fractures in the elderly [6]. Studies on the 
achievement of peak bone mass and factors that may influence it are scarce, and few population-based 
studies have been published. In the framework of the Tromsø Study in Norway we conducted a population-
based youth survey, Fit Futures (2010-2011) including more than one thousand Norwegians representing 
both urban and rural district adolescents. The objectives of the present study were to 1) describe BMD 
levels in Norwegian adolescents; 2) compare these levels with Lunar paediatric reference values, 3) identify 
predictors which may influence the acquisition of peak bone mass at the femoral sites.  
 
 
Materials and methods 
 
Study population and design: Fit Futures 
 
In 2010-2011 all first year upper secondary school students in the two neighbouring municipalities Tromsø 
and Balsfjord were invited to participate in the cross sectional study Fit Futures, which is an expansion of 
the Tromsø study [7]. The invited cohort included 1117 participants mainly aged 15 – 19 years, and 1038 
adolescents (508 girls and 530 boys) attended the survey providing an attendance rate of 92.9 % (Fig.1). 
All first year students wishing to participate were accepted, even though they were too old to be ordinary 
first year students. Since older adolescents were considered to diverge substantially in biology and 
behaviour from their younger peers, the main analyses are based on data from 469 girls and 492 boys 15-18 
years. For the comparison with the Lunar reference, we also included the 18 year old participants, similar to 
the reference. All examinations were performed during the school day in a well-established research unit 
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run by dedicated research technicians at the University Hospital of North Norway (UNN). The Norwegian 
Data Protection Authority and The Regional Committee of Medical and Health Research Ethics (reference 
number 2009/1282 and 2011/1702/REK nord) approved the study in July 2010 and October 2011, 
respectively. All participants gave written informed consent; participants aged 16 years and above signed at 




BMD at the total hip was the main outcome variable in the present study. In all participants BMD was 
measured as g/cm² at the total hip, the femoral neck and total body by dual x-ray absorptiometry (DXA) 
(GE Lunar prodigy, Lunar Corporation, Madison, WI, USA). Due to quality control and unexpected 
circumstances 10 scans were excluded. In vivo the densitometer coefficient of variation in percentage 
(CV%= [SD/mean] x 100) has been estimated to 1.17 % and 1.72 % at the total hip and femoral neck 
respectively [8], while the CV for total body BMD measurements has not been previously calculated in our 
lab. For the assessment of BMD we used the Lunar enCORE pediatric reference data [9]. As described in 
its reference list, this compilation of bone mass values collected with different LUNAR devises, by many 
researchers, without any intentional standardization, has been described in eight studies published during 
1990–2007. The reference data include mean BMD values and SD, for healthy children and adolescents 
aged 5 to 19 years, living in the USA, Australia and Northern part of Europe, neither suffering from chronic 
diseases nor using medications known to influence bone mass. The reference values are age adjusted and 
stratified for sex and ethnicity [9]. The Fit Futures adolescents Z-score was obtained using the Lunar DXA 
pediatric application, version 1.34.  
Height and weight were measured in all participants wearing light clothing without shoes. BMI was 
calculated as weight (kg) divided by the squared height (m2), and categorised in accordance with Cole et 
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Questionnaires 
 
Information about past medical history and use of medication, including contraceptives, were obtained 
through a clinical interview. At the DXA-lab technicians registered ethnicity and excluded participants with 
possible pregnancy. Information on lifestyle was collected by self-administered electronic questionnaires.  
Pubertal status in girls was determined through the following question: “If you have started menstruating, 
how old were you when you had your first menstruation?” Age at menarche was categorised into “Early” 
(<12,5 years at menarche), “Intermediate” (12,5 – 13,9 years) or “Late” (> 14 years) sexual maturation. 
Pubertal status in boys was classified according to Pubertal Developmental Scale (PDS). The boys rated 
secondary sexual characteristics as growth spurt, pubic hair growth, and changes in voice and facial hair 
growth on a scale from 1 (have not begun) to 4 (completed). Total score of the four items was summarized 
and divided in 4, in order to maintain the original range from 1-4. The answers were categorised into “Have 
not begun” (<2) “Barely started” (2- 2,9), “Underway” (3 – 3.9) or “Completed” (4). Reliability of self-
reported menarche age is well established [13], whereas the PDS originally was developed by Petersen et 
al, and has later been validated [13, 14]. The PDS-questions were included after the survey had started and 
implied considerable missing values. 
The questions on tobacco use comprised smoking and snuffing; each with three alternative answers; daily, 
sometimes or never. Alcohol consumption included drinking frequency rated from 1 (never) to 5 (four or 
more times per week). The answers were categorised into never, up to once pr. month, or more than twice a 
month. The questions on physical activity comprised type and duration of exercise and physical exertion in 
leisure time in an average week during the last year following the Gothenburg instrument [15]. The 
alternatives were four; sedentary activities, moderate activity (walking, cycling or exercises at least 4 hours 
a week), participation in recreational sports at least 4 hours a week or participation in hard training or sports 
competitions several times each week.  
We dichotomized past medical history, use of medications and contraceptives, into disease and medication 
known for their influence on bone mass, and those not, in concordance with the Lunar reference manual. 
The contraceptives were categorized into no hormonal contraceptive, oestrogens and progestin, or 
progestin-only.  




All statistical analyses were performed sex stratified. Mean and SD were calculated for continuous 
variables, and categorical variables were described in terms of number and percentage. Sex differences 
were explored by Student´s t-tests and Pearson´s chi-squared test (Table 1). For comparisons of the study 
cohort’s BMD levels with the Lunar pediatric reference at different age groups, we used the sample size 
independent “One sample t-tests for a single group” (Table 2). Due to lack of numbers of observations in 
the Lunar age groups, calculations of 95% CIs were impossible, therefore only p-values are reported. 
ANOVA with the Bonferroni correction for multiple comparisons were used to assess differences in mean 
BMD according to ethnicity, pubertal state, physical activity, other life style variables like smoking, 
snuffing and alcohol use, chronic diseases, use of medication and hormonal contraceptives. We then 
performed simple linear regression for BMD levels at the hip, crude and age adjusted (Table 3). Variables 
contributing at a 10% significance level (p<0.1), like age, height, BMI, sexual maturation, physical activity, 
smoking and alcohol consumption (in boys), together with hormonal contraceptives (in girls), diseases and 
medication known to affect bone, were used for multiple regressions analyses, modelling to the highest 
adjusted R2 (Table 4). Multiple imputations were performed for predictors and outcome variables included 
in the multivariate models, as these variables were regarded adequate for prediction of missing puberty 
values. Puberty status in girls and all other variables had less than 3% missing. We considered the main 
reason for 23% missing in the boys puberty data to be related to the late introduction of the PDS-questions, 
and we therefore assumed missing at random (MAR).  Automatic methods were used to create 5 imputed 
datasets with pooled parameter estimates reported. Confounding and interaction were explored, and 
adjustment for the interaction term between BMI and sexual maturation in girls, was included in the 
femoral neck model. In girls, we also performed analyses stratified on sexual maturation. Residual analyses 
were used to assess linearity; normal distribution, variance homogeneity and outliers, and no assumptions 
were harmed.  All analyses were performed using the Statistical Package of Social Sciences software 
(SPSS v. 22) and all values of p<0.05 were considered significant.  
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Results 
 
The study population included 508 girls and 530 boys, the majority aged 15 to 19 years; their 
characteristics are shown in Table 1. There was no difference in the BMI distribution between the sexes, 
more than 20 % were classified as overweight or obese for age. Mean age at menarche was 12.95 years (SD 
1.19). For most of the boys, sexual maturation was categorized as “Underway”. A total of 98 % of the 
participants answered the questions on lifestyle (smoking, snuffing, alcohol, physical activity). All lifestyle 
variables, except smoking, were significantly differently distributed between the sexes. The reported mean 
participation in sports outside school was 4.28 (SD 2.10) hours a week (data not shown). 
The mean BMD (SD) was 1.060 (0.124) g/cm² at the total hip, 1.066 (0.123) g/cm² at the femoral neck and 
1.142 (0.077) g/cm² at the total body in girls; BMD (SD) levels in boys were 1.116 (0.147), 1.103 (0.150) 
and 1.182 (0.097) g/cm² at the total hip, femoral neck and total body, respectively. The crude BMD values 
were significantly higher (p<0.001) at all sites in boys versus girls.  
Mean Z-score at the total hip, femoral neck and total body were positive at nearly all sites (Fig. 2). For the 
16 years old, CI for the difference did not include 0 at any of the three sites in girls, or at the total hip and 
total body in boys (Fig. 2), which indicates higher BMD levels in the FF1 population. Age stratified BMD 
levels compared to Lunar paediatric reference values, after excluding participants with comorbidities, use 
of medication or hormonal contraceptives known to influence bone mass acquisition, are shown in Table 2. 
Mean BMD values were 1.7 -7.1% higher than the reference, significantly at all three sites in girls and boys 
16 years of age (p<0.001), at femoral neck in girls aged 17 years (p= 0.014), at total hip and total body in 
boys aged 15 years (p= 0.005 and p<0.001 respectively), and at total body in boys 17 years of age 
(p=0.017).  
The univariate analyses including participants <18 years illustrated in Table 3, showed a positive 
correlation between age and BMD in boys (p< 0.001), which was not present in girls. In both sexes height, 
weight, BMI, sexual maturation, smoking and physical activity levels were significantly correlated with 
BMD. Alcohol use was in addition positively correlated with BMD at the femoral sites in boys. Adjusting 
for age only made minor changes. 
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In multivariate analyses; the determinants were height, BMI, sexual maturation, physical activity, smoking 
and alcohol intake, with differently explained variation seen among girls and boys. After imputation of 
missing values, age became significant in boys (p<0.038) on behalf of the association of sexual maturation. 
Pooled parameter estimates for the imputed models, controlled for comorbidity, medication and hormonal 
contraceptives known to influence BMD, with the highest adjusted R2, are displayed in Table 4. In boys; 
age, height, BMI, together with recreational sport, hard training and alcohol use were positively (p<0.038) 
associated with BMD, whereas smoking and an initial stage of sexual maturation (p< 0.047) were 
associated with lower BMD. Hard training boys had 13 % higher BMD levels at total hip and femoral neck 
(0.144 and 0.141 g/cm2 respectively, p<0001) compared to their sedentary peers, which equals a BMD 
difference of almost 1SD. In girls too, height, BMI and higher levels of physical activity were positively 
(p<0.047) associated with BMD, while late puberty indicated lower BMD levels at both femoral sites. 
There was a significant interaction between BMI and sexual maturation at the femoral neck. Stratified 
analyses showed that BMI was more strongly associated with femoral neck BMD levels in late sexually 
maturated girls. For girls in early menarche, BMD increased by 0.007 g/cm2 (p= 0.003) for one unit 
increase of BMI, for girls in intermediate menarche by 0.009 g/cm2 (p<0.001) and late menarche by 0.014 
g/cm2 (p< 0.001) (data not shown). Among hard training girls BMD levels were 11% higher at both sites, 
i.e. approximately 1 SD (0.117 and 0.123 g/cm2, p<0.001), respectively. Among girls participating in 
recreational sports, BMD levels at the femoral neck were significantly, but only modestly higher compared 




Despite the heavy burden of osteoporotic fractures in elderly Norwegians [4, 16, 17], BMD levels appeared 
higher in Norwegian adolescents compared to the Lunar pediatric reference data. Height, participation in 
intensive physical activity of more than four hours a week and early sexual maturation were significantly 
associated with higher BMD levels at both femoral sites in girls, whereas BMI only at the total hip. The 
corresponding variables in boys were age, height, BMI, higher physical activity levels and alcohol intake, 
whereas early stage of sexual maturation and smoking were negatively related to BMD. The highest 
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physical activity levels were associated with more than 1 SD higher BMD levels; i.e. 11 % increase in girls 
and 13 % in boys involved in sports competition or hard training. According to Rizzoli et al, a 10 % 
increase in peak bone mass corresponds to a gain of 1 SD BMD in adulthood, and a fracture risk reduction 
of up to 50% [6]. 
The differences observed in mean BMD values between the Lunar population and the Fit Futures 
adolescents could be due to calibration error, different hard-ware devices, operator technique, selection 
bias, anthropometric differences of the population (secular trends) or true population differences. Our 
Lunar Prodigy was calibrated daily according to the manufactures quality assurance manual. Different 
research technicians operated the densitometer, no intra-/inter reliability tests were made, but the 
technicians were well trained, and had operated the device daily for a long period, which should reduce the 
risk of systematic error.  A former study at the same research unit estimated the densitometer coefficient of 
variation at the total hip measured in vivo [8]. The differences reported were small and clinically irrelevant, 
as reported by others [18]. 
The Lunar reference data were collected in different studies, mainly using old pencil beam scanners (DPX-
devises). Previous studies have evaluated relationships between DPX devises and the newer narrow fan 
bean densitometers (Prodigy). In general, small differences between the two types of absorptiometry were 
found, and by use of cross-calibration equations and factors, results from the two different devices were 
considered compatible [19, 20]. 
Cross-sectional studies are vulnerable to certain biases like non-participation or survivors-bias. In Fit 
Futures approximately 14 % of the eligible population were not invited due to chronic illness, dropouts 
from school, or because the study team were unable to contact them, another 7% of the invited did not 
attend the study for unknown reasons. Dropout from school may be associated with an unhealthy life style, 
and individuals suffering from chronic illness, may also have lower BMD levels [21]. However, a 
participation rate of 93% is high, and should contribute to robust estimates.  
In comparison with the Lunar reference our mean BMD values in girls and boys were significantly higher 
(1.7-7.1%) at nearly all sites at the age of 16 and 17 years. This is in concordance with Kolle et al, who in a 
study of 145 Norwegian females aged 13-39 years, showed mean BMD values to be 3.4-5.1% higher than 
the US/European reference (p<0.005) for this age range [22]. DXA- technique tends to underestimate the 
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true density value for smaller bones and overestimates for larger bones, something that could explain our 
high BMD levels. Only two studies of the Lunar compilation [23, 24] reported the participants’ height and 
weight according to age groups, so the opportunities for comparison of anthropometric measurements were 
limited.  A study of Norwegian growth curves from 2009 shows that height and BMI have increased during 
the last 30 years [25]. The mean height of our participants was just below the 50% percentile of the 
Norwegian growth curves, and the weight somewhat higher.  Even though the Fit Futures population may 
be slightly higher and heavier than the Lunar reference, we consider the potential for overestimation due to 
height to be small, and the difference could more likely be related to weight.  
Most studies report that late menarche is associated with lower BMD [26]. In the Lunar reference, the 
puberty data, if collected, were collected in different ways. It was therefore challenging to explore the 
influence of puberty in this comparison. This was also the case for confounding factors like diet (calcium 
and vitamin D), physical activity and unhealthy lifestyle (smoking and alcohol use), which were sparsely 
described.   
There are limited newer population-based studies describing BMD values for our respective age groups. 
Except for the 17 years old boys and girls in the ALSPAC cohort, reporting higher BMD levels at the hip 
[27] , most studies report lower BMD values for total hip and total body than Fit Futures do [28-32]. After 
converting Hologic measurements to GE-Lunar [33] mostly all our mean BMD values remained higher, 
which support our conclusions; the overall tendency of higher Fit Futures than Lunar values, may be 
explained by true population differences.  
Participants reporting diseases or medication known to influence bone were few, and when excluded from 
the analyses, hardly any changes were seen. Even though one third of the girls reported use of hormonal 
contraceptives, this did not influence bone mass. In our data 4 % were classified as non-white. Exclusion of 
these participants did not change the results, and these individuals were included in the final analysis. 
Classification of Sami ethnicity was self-reported based on cultural belonging, and we were therefore 
unable to report any genetic influence from Sami heritage.  
Body weight is the largest single determinant of adult bone mass [34]. In our cohort more than 20% were 
classified as overweight or obese for age according to Cole et al´s definition of overweight and obesity in 
childhood [11]. The importance of BMI and weight in adolescence is not clearly understood.  Some studies 
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suggest a negative effect of fat mass during childhood and adolescence; obese children are more prone to 
falls and to fractures due to lower bone mass relative to body size [35]. Other studies report a positive 
association between fat mass and bone growth before puberty [36-38]. In girls it seems as puberty attenuate 
and reverse this effect between fat and bone [36]. This supports our finding; BMI was positively associated 
with BMD with higher beta values in late sexually matured girls.  
Most studies report that late commencement of puberty is associated with lower BMD in both sexes [26, 
28, 39]. For girls with intermediate and late sexual maturation, we found a negative association with BMD 
levels at the femoral neck as described by Heaney 2000; who reported that late menarche is a skeletal 
disadvantage, and that there is an association between age at menarche and fracture risk. Boys in the 
beginning of puberty had considerably lower BMD levels at the total hip compared to those with completed 
sexual maturation, as indicated by Arabi et al [28].  
A review from Bieleman et al [40] indicated that more studies have found positive associations between 
physical activity and bone mass in males than in females at weight bearing anatomical sites, and that low 
participation in peak strain activities may explain the weaker associations found in females. In our study 
both boys and girls that reported hard training had more than 1 SD higher BMD at the femoral sites, 
compared to those who were sedentary. A former Norwegian population-based study reported participation 
in sports outside school for 16-years-old youth to a mean of 3.72 (SD 2.37) hours a week [41]. Compared 
to these, our adolescents reported slightly higher physical activity levels (0.56 hours, CI [0.325-0.795]). 
Despite the lack of evidence of effect of physical activity during adolescence on later fracture risk, it is 
important to take into account its influence of physical activity practice in later life [40].  
Tobacco use has been associated with lower BMD levels in adolescence in some, but not all studies [34]. 
The effect of smoking is also influenced by dose and duration [42], which can explain diverging study 
results. Longitudinal studies of adolescent boys and girls in early adulthood have shown adverse effect of 
smoking [21, 43]. In our study, smoking was negatively associated with BMD at the hip only in boys. 
Among the Fit Futures girls, approximately 5 % reported daily smoking, compared to 15 % in Dorn et al´s 
study, which can explain the lack of significance in the multivariate model. 
In our study there were no significant associations of alcohol on BMD levels in girls, supported also by 
Dorn et al. On the contrary; in boys, alcohol consuming was significantly and positively associated to BMD 
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at the hip sites, supported by findings in adults where moderate alcohol consumption appears to be 
beneficial to men´s bone health [44, 45]. This effect has been suggested by Wosje and Kalkwarf to be 
linked to the promotion of endogenous estrogen synthesis, and thereby increasing BMD in individuals with 
low circulating estrogen concentrations [44]. Anyhow; this result must be interpreted carefully, as the 
questions about alcohol consumption has not been validated for this age group. 
The strengths of this study lie in its population-based design, high attendance rate of both sexes, and the 
representation of urban and rural adolescents, which makes the results highly representative for Norwegian 
adolescents.  The main limitation is the cross-sectional design, which limits causal inferences. The nature 
of our self-reported questions of physical activity level and sexual maturation (non-differential 
measurement errors) may weaken the associations. Also the considerable male puberty missing values may 
cause bias. A comparison of age, weight, height, BMI and BMD measurements, showed that participants 
with no puberty data were significantly younger (0.3yrs, p<0.001), with lower BMD femoral neck (0.034 
g/cm2 p=0.038) and total body (0.028 g/cm2, p=0.007) values. Since boys in the beginning of the survey 
were not offered this question, it is likely that they were younger, and therefore with lower age related 
BMD values, which supports our assumption of randomly missing puberty data.  Information on dietary 
calcium intake and vitamin D levels would also have strengthened the result.   
This study is the first to report BMD levels in Norwegian adolescents. Despite the heavy fracture risk in the 
Norwegian elderly, there is no reason to believe that mean BMD levels of todays Norwegian adolescents 
are lower compared to other European populations. Among modifiable factors, BMI and physical activity 
levels are associated with higher BMD levels in both sexes. The interaction between these two factors 
should be elaborated further, and the most optimal levels identified. The negative effect of early smoking 
on male BMD is noted, and the effect of snuffing will be followed carefully. Given the positive association 
between modest alcohol intake and BMD in males, longitudinal data will be valuable. Intermediate and late 
sexual maturation were associated with substantial lower BMD levels compared to menarche age <12.5 
years. One SD reduction in BMD values can lead to more than a doubled fracture risk in the elderly [6]. 
Therefore, longitudinal data will be highly important for following the possible adverse effect of late sexual 
maturity – will it level out?   
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In conclusion; BMD values from the Fit Futures will be a valuable supplement to other population-based 
reference values for BMD levels at the hip and total body for adolescents 16 -17 years of age.  Furthermore, 
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Figure Captions 
Fig. 1 Participation in the Tromsø Study: Fit Futures 2010-2011 
Fig. 2 BMD Z-score for age groups at total hip, femoral neck and total body, in girls and boys, the Tromsø 
Study: Fit Futures. Observations in each age group included, and statistically significant values displayed 







Registered students  (Vg1) 
School year 2010/2011  
N = 1301 
	  Invited Fit Futures 1 
N = 1117 
1
	  
Participated Fit Futures 1 
N = 1038 (92,9%) 
Quitted school before study 
start 
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with/persistent diseases 
N = 114 
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N = 77 
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Table 1 Characteristics of the study participants in The Tromsø Study: Fit Futures 2010-
2011, n=1038. Mean (SD) of continuous variables and percentage (number of 
observations) of categorical variables are given for girls and boys respectively. 
Characterics	   	   	   	  
	   n	   GIRLS	   n	   BOYS	   PEquality	  
Age, years  508	   16.94 (1.36) 530	   16.82 (1.04) 0.111 
Height, m  505	   1.65 (0.07) 529	   1.77 (0.07) <0.001 
Weight, kg  505	   61.4 (12.2) 529	   70.6 (14.6) <0.001 
BMI, kg/m2  505	   22.6 (4.2) 529	   22.5 (4.2) 0.676 
BMI class a 
Underweight for age 
Normal weight for age 
Overweight for age 
Obese for age 











BMD total hip, g/cm2  502	   1.060 (0.124) 526	   1.116 (0.147) <0.001 
BMD femur neck, g/cm2  503	   1.066 (0.123) 526	   1.103 (0.150) <0.001 




503	   	  
94.9 (482) 
4.2 (21)	  




Puberty girls  
Age at menarche  
Sexual maturation  
Early (<12,5 yrs) 
Intermediate (12.5 – 13.9) 
Late (> 14) 







































































Up to once pr. month 
Twice or more pr. month 









a BMI class: Age < 18 years; Coles index according to sex and age, Age > 18 years; 
WHOs index 




















> 3 diseases 















> 3 medications 











Hormonal contraceptives  
Yes 
oestrogen and progestogens 
progestogens only 




	   	    
Table 2 The Tromsø Study: Fit Futures BMD values (g/cm2) excluded participants using hormonal contraceptives, with diseasesa, or 
medicationb known to affect BMD, compared to Lunar Pediatric referencec, described as mean (SD) at different age groups, sex and 
sites. Differences displayed in percentage, significant result (p<0.05) in bold 






















































































































































a Diseases (ICD10) known to affect bone:  
   E03 Hypothyroidism, E10 Diabetes type I, F50.9 Eating disorders, K90.0 Celiac disease, M13 Arthritis 
b Medication (ATC) known to affect bone:  
  D07A Plain corticosteroids, H03A Thyroid preparations, N03A Antiepileptic,  
  R01AD Corticosteroids, R03BA Glucocorticoids (inhalants), H02A Corticosteroid for systemic use 
c Lunar enCore, Supplement til pediatrisk referansedata. 1. revision ed: GE Healthcare; 2010-Nov 
Table 3 Association between basic characteristics, lifestyle variables and BMD (g/cm2) at total hip and femoral neck in girls and boys 
<18 years (univariate linear regression analyses), The Tromsø Study: Fit Futures. Statistically significant results at 10% level 




Total hip Femoral neck 
Crude Age adjusted Crude Age adjusted 
GIRLS n = 469 Beta p-value Beta p-value Beta p-value Beta p-value 
Age (years) 0.010 0.461   0.014 0.310   
Height (m)  0.002 0.027 0.002 0.030 0.003 < 0.001 0.003 < 0.001 
Weight (kg) 0.004 < 0.001 0.004 < 0.001 0.004 < 0.001 0.004 < 0.001 
BMI (kg/m2) 0.010 < 0.001 0.010 < 0.001 0.009 < 0.001 0.009 < 0.001 
Ethnicity (White/Other) 0.008 0.840 0.006 0.879 -0.007 0.857 -0.009 0.803 
Sexual maturation Reference: Menarche age < 12.5 years 
Intermediate  -0.027 0.036 -0.027 0.038 -0.027 0.040 -0.026 0.042 
Late  -0.053 0.001 -0.054 0.001 -0.055 < 0.001 -0.055 < 0.001 
Smoking (No/Yes) -0.025 0.077 -0.026 0.074 -0.030 0.033 -0.031 0.031 
Snuffing (No/Yes) -0.003 0.821 -0.004 0.764 -0.003 0.786 -0.004 0.712 
Alcohol use (No/Yes) -0.013 0.320 -0.014 0.294 -0.012 0.369 -0.013 0.330 
Physical Activity Reference: Sedentary 
Moderate  0.012 0.473 0.013 0.461 0.016 0.356 0.016 0.340 
Sports 0.031 0.087 0.031 0.086 0.037 0.037 0.037 0.036 
Hard training  0.113 < 0.001 0.112 < 0.001 0.118 < 0.001 0.118 < 0.001 
Comorbidity (No/Yes) 0.006 0.616 0.005 0.662 0.006 0.636 0.005 0.699 
Diseases known to 
affect bone a (No/Yes) 
-0.019 0.726 -0.019 0.733 -0.041 0.454 -0.041 0.461 
Medication daily 
(No/Yes) 
0.003 0.820 0.003 0.824 0.001 0.928 0.001 0.935 
Medication known to 
affect bone b (No/Yes) 
-0.041 0.232 -0.042 0.225 -0.036 0.292 -0.037 0.281 
Hormonal 
contraceptives 
Reference: No use of hormonal contraceptives 
Oestrogens & 
progestin  
-0.001 0.959 -0.002 0.861 0.004 0.753 0.002 0.881 




Total hip Femoral neck 
Crude Age adjusted Crude Age adjusted 
BOYS n = 492 Beta p-value Beta p-value Beta p-value Beta p-value 
Age (years) 0.058 <0.001   0.072 < 0.001   
Height (m) 0.004 < 0.001 0.004 < 0.001 0.006 < 0.001 0.006 < 0.001 
Weight (kg) 0.004  <0.001 0.004 < 0.001 0.004 < 0.001 0.004 < 0.001 
BMI (kg/m2) 0.011 < 0.001 0.011 <0.001 0.012 < 0.001 0.012 < 0.001 
Ethnicity (White/Other) 0.072 0.122 0.058 0.217 0.076 0.115 0.057 0.227 
Sexual maturation Reference: Completed (PDS 4) 
Underway  -0.042 0.123 -0.036 0.189 -0.057 0.036 -0.050 0.066 
Just started  -0.074 0.020 -0.066 0.037 -0.112 < 0.001 -0.103 0.001 
Smoking (No/Yes) -0.035 0.027 -0.039 0.012 -0.020 0.223 -0.025 0.116 
Snuffing (No/Yes) -0.001 0.964 -0.002 0.891 0.012 0.374 0.011 0.428 
Alcohol use (No/Yes) 0.028 0.050 0.027 0.057 0.031 0.032 0.030 0.037 
Physical Activity Reference: Sedentary 
Moderate  0.012 0.453 0.011 0.492 0.025 0.143 0.023 0.168 
Sports 0.092 < 0.001 0.089 < 0.001 0.108 < 0.001 0.104 < 0.001 
Hard training  0.154 < 0.001 0.148 < 0.001 0.155 < 0.001 0.147 < 0.001 
Comorbidity (No/Yes) -0.017 0.262 -0.020 0.168 -0.008 0.585 -0.013 0.394 
Diseases known to 
affect bonea (No/Yes) 
-0.057 0.346 -0.060 0.318 -0.063 0.309 -0.066 0.276 
Medication daily 
(No/Yes) 
-0.007 0.637 -0.010 0.508 -0.006 0.702 -0.009 0.542 
Medication known to 
affect boneb (No/Yes) 
-0.044 0.377 0.050 0.309 -0.036 0.475 -0.044 0.381 
 
a Diseases (ICD10) known to affect bone:  
   E03 Hypothyroidism, E10 Diabetes type I, F50.9 Eating disorders, K90.0 Celiac disease, M13 Arthritis 
b Medication (ATC) known to affect bone:  
  D07A Plain corticosteroids, H03A Thyroid preparations, N03A Antiepileptics,  
  R01AD Corticosteroids, R03BA Glucocorticoids (inhalants), H02A Corticosteroid for systemic use 
 
Table 4 Pooled parameter estimates after multiple imputations a in the multivariate linear regression models b with the highest adjusted R2, 
explaining associations between basic characteristics, lifestyle variables and BMD (g/cm2) at total hip and femoral neck in girls and boys <18 
years, adjusted for possible confounders c,d. Statistically significant result (p<0.05) in bold. The Tromsø Study: Fit Futures  
 
 FEMALES n = 469 MALES n = 492 
 Total hip  Femoral neck  Total hip  Femoral neck 
Beta p-value Beta p-value Beta p-value Beta p-value 
Age (years) 0.017 0.197 0.017 0.177 0.030 0.038 0.035 0.013 
BMI (kg/cm2) 0.011 <0.001 0.002 0.533 0.012 <0.001 0.012 < 0.001 
Height (cm) 0.002 0.011 0.003 <0.001 0.002 0.014 0.004 < 0.001 
Sexual maturation: Reference: Menarche age < 12,5 years Reference: Completed 
Intermediate /Underway -0.028 0.019 - 0.124 0.002 -0.020 0.388 -0.027 0.241 
Late /Just started -0.051 <0.001 - 0.236 0.002 -0.035 0.198 -0.054 0.047 
Physical activity: Reference: Sedentary 
Moderate  0.004 0.810 0.009 0.582 0.007 0.640 0.016 0.272 
Sports  0.023 0.170 0.033 0.047 0.077 < 0.001 0.091 < 0.001 
Hard training  0.117 <0.001 0.123 <0.001 0.144 < 0.001 0.141 < 0.001 
Alcohol (No/Yes)     0.035 0.006 0.028 0.021 
Smoke (No/Yes)     -0.029 0.037   
BMI*Sexual maturation   0.004 0.017     
Diseases known to affect bonec 
(No/Yes) 
-0.013 0.793 -0.032 0.512 -0.023 0.648 -0.018 0.718 
Medication known to affect boned 
(No/Yes) 
-0.036 0.245 -0.036 0.237 -0.074 0.078 -0.065 0.124 
Hormonal contraceptives Reference: No hormonal contraceptives     
Oestrogens & progestin -0.006 0.563 0.000 0.987     
Progestin-only -0.006 0.800 0.005 0.839     
 Adjusted R2: 22.9% Adjusted R2: 24.3% Adjusted R2: 32% Adjusted R2: 34.7% 
 
a Variables included in the imputation procedure: 
Sex, age, height, weight, BMI, alcohol, smoke, physical activity, menarche age, PDS-score, hormonal contraceptives, medication and diagnosis                                              
known to affect bone, BMD total hip and femoral neck 
b Variables with p-values<0.1 in univariate analyses included 
c Diseases (ICD10) known to affect bone:  
 E03 Hypothyroidism, E10 Diabetes type I, F50.9 Eating disorders, K90.0 Celiac disease, M13 Arthritis 
d Medication (ATC) known to affect bone:  
D07A Plain corticosteroids, H03A Thyroid preparations, N03A Antiepileptics, R01AD Corticosteroids, R03BA Glucocorticoids (inhalants), 
H02A Corticosteroid for systemic use 
 
 
